Your session is about to expire
← Back to Search
Other
Medication - Gabapentin for Facial Pain
Phase 4
Waitlist Available
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights
Study Summary
This study is evaluating whether a medication may help reduce pain following oral surgery.
Eligible Conditions
- Facial Pain
- Postoperative Pain
- Acute Pain
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Intensity of pain
incidence of adverse effects
time to first rescue analgesic
+1 moreSecondary outcome measures
incidence of pain
intensity of pain on a numeric rating scale (0-10)
length of post-operative hospital-stay
Side effects data
From 2021 Phase 4 trial • 88 Patients • NCT030128152%
Allergic reaction
100%
80%
60%
40%
20%
0%
Study treatment Arm
Gabapentin
Benzodiazepine
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Medication - GabapentinExperimental Treatment1 Intervention
Participants of this group will be administered either Gabapentin 900 milligram PO 2-3 hours prior to the surgical procedure.
Group II: Medication - PlaceboPlacebo Group1 Intervention
Participants of this group will be administered either Placebo PO 2-3 hours prior to the surgical procedure.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Gabapentin
FDA approved
Find a Location
Who is running the clinical trial?
Massachusetts General HospitalLead Sponsor
2,928 Previous Clinical Trials
13,198,355 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger